TMEM215

TMEM215 is an endoplasmic reticulum-resident two-pass transmembrane protein required for endothelial cell survival during angiogenesis and vascular remodeling (PMID:30370660, PMID:37750320). It binds the ER chaperone BiP (GRP78) and bridges BiP to the BH3-only proapoptotic protein BIK, thereby restraining ER-to-mitochondrial Ca2+ transfer: loss of TMEM215 expands mitochondria-associated ER membrane (MAM) contacts and drives mitochondrial Ca2+ influx, with the resulting apoptosis blocked by IP3R or MCU inhibition, placing TMEM215 upstream of BIK-triggered Ca2+ flux and cell death (PMID:37750320). In endothelial cells its expression is induced by physiological laminar shear stress through downregulation of the histone methyltransferase EZH2, and EC-specific deletion impairs retinal vessel regression with increased EC apoptosis, linking TMEM215 to shear-stress-controlled protection of cells during vessel pruning (PMID:37750320). Beyond the vasculature, TMEM215 nucleates a Ca2+-dependent ANXA2-TMEM215-BiP complex at ER-mitochondria contact sites that promotes PINK1/Parkin-mediated mitophagy and anoikis resistance in endometrial stromal cells (PMID:42037208).

1. 2011 Low

   An initial proteomic screen asked whether TMEM215 engages PDZ-scaffold proteins, offering the first candidate interaction partners before any cellular role was known.

   Evidence PDZ domain microarray and peptide binding assays with MAGI1/SCRIB PDZ domains

   PMID:22069443

   Open questions at the time

   • Single peptide binding assay in a high-false-positive-rate context, explicitly described as putative
   • No cellular or functional validation of MAGI1/SCRIB binding
   • Interaction never reconnected to the later ER/apoptosis biology
2. 2018 Medium

   The first functional study established that TMEM215 is an endothelial two-pass transmembrane protein essential for EC survival, defining its phenotype before its molecular mechanism.

   Evidence 5'-RACE, IF co-localization with EC markers, siRNA knockdown with viability/sprouting assays, and intravitreous siRNA in mouse retina

   PMID:30370660

   Open questions at the time

   • No binding partners identified in this study
   • Subcellular ER localization not yet established
   • Molecular cause of apoptosis upon knockdown unknown
3. 2023 High

   Two coordinated studies resolved the molecular mechanism — ER localization, BiP/BIK binding, control of MAM Ca2+ flux — and placed TMEM215 downstream of shear-stress/EZH2 signaling in vessel pruning.

   Evidence IP-MS for partners, siRNA with BCL-2/IP3R/MCU rescue, EM MAM quantification, shear stress and EZH2 manipulation, and EC-specific conditional knockout mice with retinal phenotyping

   PMID:37750320

   Open questions at the time

   • Structural basis of the TMEM215-BiP-BIK assembly not defined
   • How TMEM215 mechanically limits MAM contacts is unresolved
   • Whether EZH2 acts directly on the TMEM215 locus not shown
4. 2026 Medium

   A study in endometrial stromal cells extended TMEM215 function beyond endothelium, showing it assembles a Ca2+-dependent ANXA2-TMEM215-BiP complex that drives mitophagy and anoikis resistance.

   Evidence Co-IP and IP-MS for ANXA2/BiP, siRNA knockdown, PINK1/Parkin mitophagy and ER-mitochondria contact assays, and a mouse endometriosis model

   PMID:42037208

   Open questions at the time

   • Single lab, single study without independent replication
   • Mechanistic relationship between apoptosis-restraining and mitophagy-promoting roles unclear
   • Direct ANXA2-TMEM215 binding interface not mapped

• How TMEM215 physically governs ER-mitochondria contact architecture and reconciles its dual roles in suppressing apoptosis versus promoting mitophagy across cell types remains unresolved.
• No structural model of TMEM215 or its complexes
• Mechanism coupling BiP binding to MAM Ca2+ flux not defined
• Generality of the ANXA2 complex beyond endometrial cells untested